ReviewTherapeutic advances in medical oncology2022

Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines.

Christine Simmons et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.